Keep in Touch: FEIBA [Anti-Inhibitor Coagulant Complex]

LET’s KEEP IN TOUCH.

Stay up-to-date with info on inhibitors, stories of real patients, Shire resources, and much more. Complete your sign-up and you'll get interesting info—right in your inbox.

I am:
Tell us about you:
Patient Information

Children should get their parent’s or guardian’s consent before providing any personally identifiable information. This site does not seek to collect personal information from children under the age of 13 and will not retain this information if aware of its receipt. We respect your privacy. The information you provide will only be used for purposes for which you have provided it. Please note that when you contact Shire directly, you submit personally identifiable information, you consent to its disclosure and use for these purposes. We may share your information with our partners who facilitate the delivery of this information. If you ever decide that you do not wish to receive information from us regarding our programs and services, contact us at: Shire Customer Service, Shire US Inc., 1200 Lakeside Drive, Bannockburn, IL 60015 or at 1-800-423-2090. If you have any questions, comments, concerns, or complaints about our information practices, call 1-844-229-2582 (U.S.) or 224-940-5832 (outside of the U.S.), fax your inquiry to 224-940-5833, or send us mail at Shire Connect, 1200 Lakeside Drive, Bannockburn, IL 60015.

Child Privacy

This site does not seek to collect personal information from children under the age of 13 years. At any Web site, including the nonchildren portions of this Web site, children should get their parent’s or guardian’s consent before giving any personal information.

For more information, see our Privacy Statement.

This information is intended only for residents of the United States.

Baxalta and FEIBA are trademarks of Shire plc.

FEIBA [Anti-Inhibitor Coagulant Complex] Indications

What is FEIBA used for?
FEIBA (Anti-Inhibitor Coagulant Complex) is used for people with Hemophilia A or B with Inhibitors to control and prevent bleeding episodes, before surgery, or routinely to prevent or reduce the number of bleeding episodes. It is NOT used to treat bleeding conditions without inhibitors to Factor VIII or Factor IX.

Detailed Important Risk Information

When should I not take FEIBA?
You should not take FEIBA if you have had hypersensitivity or an allergic reaction to FEIBA or any of its components, including factors of the kinin generating system, if you have a condition called Disseminated Intravascular Coagulation, which is small blood clots in various organs throughout the body, or currently have blood clots or are having a heart attack. Make sure to talk to your healthcare provider about your medical history.

What Warnings should I know about FEIBA?
FEIBA can cause blood clots, including clots in the lungs, heart attack, or stroke, particularly after high doses of FEIBA or in people with a high risk of blood clots. Patients that have a risk of developing blood clots should discuss the risks and benefits of FEIBA with their healthcare provider since FEIBA may cause blood clots. FEIBA can cause hypersensitivity or allergic reactions and infusions site reactions, and these reactions can be serious. Because FEIBA is made from human plasma, it may carry the risk of transmitting infectious agents, for example, viruses, including Creutzfeldt-Jakob disease (CJD) agent, and the variant CJD agent. Although steps have been taken to minimize the risk of virus transmission, there is still a potential risk of virus transmission.

What should I tell my healthcare provider?
Make sure to discuss all health conditions and medications with your healthcare provider. If you are pregnant or are planning to become pregnant, or are a nursing mother, make sure to talk with your healthcare provider for advice on using FEIBA.

What are the side effects of FEIBA?
The most frequent side effects of FEIBA are: low red blood cell count, diarrhea, joint pain, hepatitis B surface antibody positivity, nausea, and vomiting. The most serious side effects of FEIBA include: hypersensitivity reactions, including anaphylaxis, stroke, blood clots in the lungs, and blood clots in the veins. Always immediately talk with your healthcare provider if you think you are experiencing a side effect.

What other medications might interact with FEIBA?
The use of other clotting agents with FEIBA is not recommended, for example, tranexamic acid and aminocaproic acid. Be sure to talk with your healthcare provider and pharmacist about all medications and supplements you are taking.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The risk information provided here is not comprehensive. To learn more, talk about FEIBA with your healthcare provider or pharmacist. The FDA-approved product labeling can be found at http://www.feiba.com/us/forms/feiba_pi.pdf or by calling 1-800-423-2090 and selecting option 5.